SMTL ID : 2ws7.1

Semi-synthetic analogue of human insulin ProB26-DTI

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.59 Å

Oligo State

hetero-6-6-mer

Ligands

6 x IPH: PHENOL(Non-covalent)

IPH.1: 8 residues within 4Å: Chain A: C.6, S.9, I.10, C.11 Chain B: C.7, H.10, L.11, A.14 6 PLIP interactions: 1 interactions with chain F, 2 interactions with chain A, 3 interactions with chain B pi-Cation interactions: F:H.5 Hydrogen bonds: A:C.6, A:C.11 Hydrophobic interactions: B:H.10, B:L.11, B:A.14 IPH.4: 7 residues within 4Å: Chain C: C.6, S.9, I.10, C.11 Chain D: L.11 Chain J: L.17 Chain L: L.6 6 PLIP interactions: 3 interactions with chain C, 1 interactions with chain D, 1 interactions with chain J, 1 interactions with chain L Hydrophobic interactions: C:I.10, D:L.11, J:L.17, L:L.6 Hydrogen bonds: C:C.6, C:C.11 IPH.7: 9 residues within 4Å: Chain E: C.6, S.9, I.10, C.11 Chain F: C.7, H.10, L.11, A.14 Chain J: H.5 7 PLIP interactions: 3 interactions with chain F, 3 interactions with chain E, 1 interactions with chain J Hydrophobic interactions: F:H.10, F:L.11, F:A.14, E:I.10 Hydrogen bonds: E:C.6, E:C.11 pi-Stacking: J:H.5 IPH.8: 8 residues within 4Å: Chain D: V.2, H.5 Chain G: C.6, S.9, I.10, C.11 Chain H: H.10, A.14 6 PLIP interactions: 2 interactions with chain H, 2 interactions with chain D, 2 interactions with chain G Hydrophobic interactions: H:H.10, H:A.14, D:V.2 pi-Cation interactions: D:H.5 Hydrogen bonds: G:C.6, G:C.11 IPH.9: 10 residues within 4Å: Chain B: V.2, H.5 Chain I: C.6, S.9, I.10, C.11, L.16 Chain J: H.10, L.11, A.14 7 PLIP interactions: 1 interactions with chain B, 3 interactions with chain J, 3 interactions with chain I pi-Stacking: B:H.5 Hydrophobic interactions: J:H.10, J:L.11, J:A.14, I:L.16 Hydrogen bonds: I:C.6, I:C.11 IPH.10: 7 residues within 4Å: Chain K: C.6, I.10, C.11 Chain L: C.7, H.10, L.11, A.14 4 PLIP interactions: 2 interactions with chain L, 2 interactions with chain K Hydrophobic interactions: L:H.10, L:A.14 Hydrogen bonds: K:C.6, K:C.11

2 x ZN: ZINC ION(Non-covalent)

ZN.2: 4 residues within 4Å: Chain B: H.10 Chain F: H.10 Chain J: H.10 Ligands: CL.3 3 PLIP interactions: 1 interactions with chain F, 1 interactions with chain J, 1 interactions with chain B Metal complexes: F:H.10, J:H.10, B:H.10 ZN.5: 4 residues within 4Å: Chain D: H.10 Chain H: H.10 Chain L: H.10 Ligands: CL.6 3 PLIP interactions: 1 interactions with chain L, 1 interactions with chain H, 1 interactions with chain D Metal complexes: L:H.10, H:H.10, D:H.10

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 7 residues within 4Å: Chain B: L.6, H.10 Chain F: L.6, H.10 Chain J: L.6, H.10 Ligands: ZN.2 Ligand excluded by PLIP CL.6: 6 residues within 4Å: Chain D: L.6, H.10 Chain H: L.6, H.10 Chain L: H.10 Ligands: ZN.5 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jiracek, J. et al., Implications for the Active Form of Human Insulin Based on the Structural Convergence of Highly Active Hormone Analogues. Proc.Natl.Acad.Sci.USA (2010)

Release Date

2010-02-09

Peptides

INSULIN A CHAIN: ACEGIK
INSULIN B CHAIN: BDFHJL

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
C

E
E

G
G

I
I

K
K

B
B

D
D

F
F

H
H

J
J

L
L

INSULIN A CHAIN

INSULIN B CHAIN

Related Entries With Identical Sequence